Michael H Carrel is President, CEO, & Director of AtriCure, Inc.. Currently has a direct ownership of 653,239 shares of ATRC, which is worth approximately $23.3 Million. The most recent transaction as insider was on Dec 17, 2020, when has been sold 75,000 shares (Common Stock) at a price of $10.95 per share, resulting in proceeds of $821,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 653K
0% 3M change
9.72% 12M change
Total Value Held $23.3 Million

MICHAEL H CARREL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2020
BUY
Exercise of conversion of derivative security
$821,250 $10.95 p/Share
75,000 Added 12.41%
529,504 Common Stock

Also insider at

AXNX
Axonics, Inc. Healthcare
MHC

Michael H Carrel

President, CEO, & Director
Mason, OH

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC